Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mu-He Chen

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Chemical Communications (Cambridge, England)|August 7, 2014
Cyclometalated Ir(III) complexes as targeted theranostic anticancer therapeutics: combining HDAC inhibition with photodynamic therapyRui-Rong Ye, Cai-Ping Tan, Liang He, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 24, 2016
Mono- and Dinuclear Phosphorescent Rhenium(I) Complexes: Impact of Subcellular Localization on Anticancer MechanismsRui-Rong Ye, Cai-Ping Tan, Mu-He Chen, et al.
ACS Applied Materials & Interfaces|March 28, 2017
Light-Up Mitophagy in Live Cells with Dual-Functional Theranostic Phosphorescent Iridium(III) ComplexesMu-He Chen, Fang-Xin Wang, Jian-Jun Cao, et al.
ACS Applied Materials & Interfaces|November 16, 2017
Dual Functions of Cyclometalated Iridium(III) Complexes: Anti-Metastasis and Lysosome-Damaged Photodynamic TherapyFang-Xin Wang, Mu-He Chen, Yan-Nan Lin, et al.
Scientific Reports|December 14, 2016
Ester-Modified Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer AgentsFang-Xin Wang, Mu-He Chen, Xiao-Ying Hu, et al.
Chemical Science|June 5, 2018
Cyclometalated iridium(iii) complexes as lysosome-targeted photodynamic anticancer and real-time tracking agentsLiang He, Yi Li, Cai-Ping Tan, et al.
Journal of Medicinal Chemistry|March 1, 2019
Anticancer Cyclometalated Iridium(III) Complexes with Planar Ligands: Mitochondrial DNA Damage and Metabolism DisturbanceJian-Jun Cao, Yue Zheng, Xiao-Wen Wu, et al.
Frontiers in Immunology|March 18, 2025
Targeting cGAS-STING: modulating the immune landscape of hepatic diseasesFeng Xue, Yong-Kang Liu, Xiao-Ying Chen, et al.
Chemical Science|May 22, 2018
Targeting cancer cell metabolism with mitochondria-immobilized phosphorescent cyclometalated iridium(iii) complexesJian-Jun Cao, Cai-Ping Tan, Mu-He Chen, et al.
Chemical Communications (Cambridge, England)|December 6, 2016
Tumor-targeted supramolecular nanoparticles self-assembled from a ruthenium-β-cyclodextrin complex and an adamantane-functionalized peptideShan-Shan Xue, Cai-Ping Tan, Mu-He Chen, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Chemical Communications (Cambridge, England)|August 7, 2014
Cyclometalated Ir(III) complexes as targeted theranostic anticancer therapeutics: combining HDAC inhibition with photodynamic therapyRui-Rong Ye, Cai-Ping Tan, Liang He, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 24, 2016
Mono- and Dinuclear Phosphorescent Rhenium(I) Complexes: Impact of Subcellular Localization on Anticancer MechanismsRui-Rong Ye, Cai-Ping Tan, Mu-He Chen, et al.
ACS Applied Materials & Interfaces|March 28, 2017
Light-Up Mitophagy in Live Cells with Dual-Functional Theranostic Phosphorescent Iridium(III) ComplexesMu-He Chen, Fang-Xin Wang, Jian-Jun Cao, et al.
ACS Applied Materials & Interfaces|November 16, 2017
Dual Functions of Cyclometalated Iridium(III) Complexes: Anti-Metastasis and Lysosome-Damaged Photodynamic TherapyFang-Xin Wang, Mu-He Chen, Yan-Nan Lin, et al.
Scientific Reports|December 14, 2016
Ester-Modified Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer AgentsFang-Xin Wang, Mu-He Chen, Xiao-Ying Hu, et al.
Chemical Science|June 5, 2018
Cyclometalated iridium(iii) complexes as lysosome-targeted photodynamic anticancer and real-time tracking agentsLiang He, Yi Li, Cai-Ping Tan, et al.
Journal of Medicinal Chemistry|March 1, 2019
Anticancer Cyclometalated Iridium(III) Complexes with Planar Ligands: Mitochondrial DNA Damage and Metabolism DisturbanceJian-Jun Cao, Yue Zheng, Xiao-Wen Wu, et al.
Frontiers in Immunology|March 18, 2025
Targeting cGAS-STING: modulating the immune landscape of hepatic diseasesFeng Xue, Yong-Kang Liu, Xiao-Ying Chen, et al.
Chemical Science|May 22, 2018
Targeting cancer cell metabolism with mitochondria-immobilized phosphorescent cyclometalated iridium(iii) complexesJian-Jun Cao, Cai-Ping Tan, Mu-He Chen, et al.
Chemical Communications (Cambridge, England)|December 6, 2016
Tumor-targeted supramolecular nanoparticles self-assembled from a ruthenium-β-cyclodextrin complex and an adamantane-functionalized peptideShan-Shan Xue, Cai-Ping Tan, Mu-He Chen, et al.
Pageof 2